ライフサイエンスコーパス: rhinosinusitis

1 in particular those of patients with chronic rhinosinusitis.

2 was a risk factor for noninfectious rhinitis/rhinosinusitis.

3 can arbitrarily be divided into rhinitis and rhinosinusitis.

4 characteristics very similar to eosinophilic rhinosinusitis.

5 the relationship between work exposures and rhinosinusitis.

6 eased incidences of sinonasal infections and rhinosinusitis.

7 onization, fungus balls, and allergic fungal rhinosinusitis.

8 seases ranging from colonization to invasive rhinosinusitis.

9 fungal sinusitis, and acute fulminant fungal rhinosinusitis.

10 review the diagnosis and treatment of acute rhinosinusitis.

11 r of spontaneously resolving acute bacterial rhinosinusitis.

12 childhood asthma, food allergy, and allergic rhinosinusitis.

13 sinusitis who present for treatment of acute rhinosinusitis.

14 rhinitis, nonallergic rhinitis, and chronic rhinosinusitis.

15 epithelial cells from patients with chronic rhinosinusitis.

16 but is impaired during chronic inflammatory rhinosinusitis.

17 gnificantly impaired in chronic inflammatory rhinosinusitis.

18 ergy, eosinophilic esophagitis, and allergic rhinosinusitis.

19 iseases, such as cystic fibrosis and chronic rhinosinusitis.

20 reating patients with upper airway bacterial rhinosinusitis.

21 ntly been associated with asthma and chronic rhinosinusitis.

22 Among patients with acute rhinosinusitis, a 10-day course of amoxicillin compared

23 In patients with chronic rhinosinusitis, a novel endotyping approach purely based

24 e report herein two cases of allergic fungal rhinosinusitis accompanied by bone destruction of the ad

25 Acute exacerbations of chronic rhinosinusitis (AECRS) are commonly triggered by rhinovi

26 Final diagnosis was allergic fungal rhinosinusitis (AFRS) in both cases.

27 Allergic fungal rhinosinusitis (AFRS) is a severe phenotype of chronic r

28 ALI cultures of adults with chronic rhinosinusitis (AG/AA, n = 19; GG, n = 19) were challeng

29 urpose was to classify acute invasive fungal rhinosinusitis (AIFR) caused by Mucor versus Aspergillus

30 ts with CRS had a higher prevalence of acute rhinosinusitis, allergic rhinitis, chronic rhinitis, ast

31 A total of 22 patients with chronic rhinosinusitis and 22 healthy controls (2 [5%] were aged

32 ays, such as otitis media, adenotonsillitis, rhinosinusitis and adenoid hypertrophy.

33 or the clinical diagnosis of acute bacterial rhinosinusitis and for those with severe rhinosinusitis

34 e (N-ERD) asthma is characterized by chronic rhinosinusitis and intolerance of aspirin and other COX1

35 nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role in type

36 nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role in type

37 All of the patients had chronic rhinosinusitis and nasal polyposis, and these responses

38 n accordance with the European guidelines on rhinosinusitis and nasal polyps (EPOS 2012), CT is used

39 according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) together with sin

40 A was associated with a higher prevalence of rhinosinusitis and nasal polyps as well as eosinophilia

41 RS defined by the European Position Paper on Rhinosinusitis and Nasal Polyps.

42 At the one-year follow-up, no recurrence of rhinosinusitis and olfactory disorder was observed.

43 exact role of microbial biofilms in chronic rhinosinusitis and orbital cellulitis were not elucidate

44 ability of the clinical isolates in chronic rhinosinusitis and orbital cellulitis, and to look for t

45 ential of these organisms in causing chronic rhinosinusitis and orbital cellulitis.

46 fections, chronic invasive and granulomatous rhinosinusitis, and aspergillus bronchitis.

47 adult-onset asthma, nasal polyposis, chronic rhinosinusitis, and aspirin sensitivity.

48 mation as seen in allergic rhinitis, chronic rhinosinusitis, and asthma.

49 ronic obstructive pulmonary disease, chronic rhinosinusitis, and asthma.

50 and treatment of allergic rhinitis, chronic rhinosinusitis, and asthma.

51 act diseases including otitis media, chronic rhinosinusitis, and exacerbations of both cystic fibrosi

52 tissue homogenates in patients with chronic rhinosinusitis, and this effect was most prominent in CR

53 espiratory tract infection," "pharyngitis," "rhinosinusitis," and "the common cold." HIGH-VALUE CARE

54 opriate antibiotic use for adults with acute rhinosinusitis apply to the diagnosis and treatment of a

55 Bacterial and viral rhinosinusitis are difficult to differentiate on clinica

56 features mimic essential aspects of chronic rhinosinusitis-associated olfactory loss, and illuminate

57 bservations establish a mechanism of chronic rhinosinusitis-associated olfactory loss, caused by a fu

58 To explore the mechanisms underlying rhinosinusitis-associated olfactory loss, we have genera

59 Airway diseases such as chronic rhinosinusitis, asthma, and chronic obstructive pulmonar

60 usitis recommend that the diagnosis of acute rhinosinusitis be based on the presence of "cardinal sym

61 RD) is a risk factor for developing rhinitis/rhinosinusitis, but data are lacking.

62 ad prevalence of allergic, viral and chronic rhinosinusitis, but how the brain encodes and maintains

63 n mediate corticosteroid efficacy in chronic rhinosinusitis, but the role of MUC1 in uncontrolled sev

64 Acute viral rhinosinusitis can be difficult to distinguish from acut

65 lling to travel longer distances for chronic rhinosinusitis care, results suggest that distance trave

66 l reflux disease, postnasal drip syndrome or rhinosinusitis, chronic obstructive pulmonary disease, p

67 specimens derived from patients with chronic rhinosinusitis compared to control patients.

68 e at an increased risk of developing chronic rhinosinusitis compared with controls.

69 Chronic rhinosinusitis (CRS) and asthma commonly co-occur.

70 Allergic rhinitis (AR), chronic rhinosinusitis (CRS) and asthma often co-exist.

71 Chronic rhinosinusitis (CRS) and bronchiectasis commonly co-occu

72 Chronic rhinosinusitis (CRS) and chronic periodontitis (CP) are

73 ic sinonasal inflammation, including chronic rhinosinusitis (CRS) and cystic fibrosis.

74 Asthma and chronic rhinosinusitis (CRS) are common chronic inflammatory dis

75 and immune pathways associated with chronic rhinosinusitis (CRS) are not fully understood.

76 nisms of activation in patients with chronic rhinosinusitis (CRS) are not known.

77 iotic therapy is often initiated for chronic rhinosinusitis (CRS) based on symptomatology.

78 Asthma and chronic rhinosinusitis (CRS) both impair quality of life, but th

79 oraxella species in both healthy and chronic rhinosinusitis (CRS) cohorts.

80 It is increasingly recognized that chronic rhinosinusitis (CRS) comprises a spectrum of different d

81 ovide composite criteria to evaluate chronic rhinosinusitis (CRS) control, taking into consideration

82 Chronic rhinosinusitis (CRS) defines a group of disorders charac

83 Chronic rhinosinusitis (CRS) epidemiology has been largely studi

84 Chronic rhinosinusitis (CRS) has a broad range of comorbidities.

85 Chronic rhinosinusitis (CRS) has a complex and multifactorial pa

86 Chronic rhinosinusitis (CRS) has been associated with anxiety an

87 Chronic rhinosinusitis (CRS) has been known as a disease with st

88 Chronic rhinosinusitis (CRS) has been linked to the gram-positiv

89 in and its function in patients with chronic rhinosinusitis (CRS) have not been fully explored.

90 e of asthma and its association with chronic rhinosinusitis (CRS) have not been widely studied in pop

91 Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regard

92 criteria to study the prevalence of chronic rhinosinusitis (CRS) in a general-population sample.

93 robial interactions in patients with chronic rhinosinusitis (CRS) in hopes of elucidating mechanisms

94 Chronic rhinosinusitis (CRS) is a chronic inflammatory condition

95 Chronic rhinosinusitis (CRS) is a chronic inflammatory disease a

96 Chronic rhinosinusitis (CRS) is a clinical syndrome defined by t

97 Chronic rhinosinusitis (CRS) is a common chronic inflammatory di

98 Chronic rhinosinusitis (CRS) is a common chronic inflammatory di

99 Chronic rhinosinusitis (CRS) is a common chronic respiratory con

100 Chronic rhinosinusitis (CRS) is a common clinical syndrome that

101 Chronic rhinosinusitis (CRS) is a common condition associated wi

102 Chronic rhinosinusitis (CRS) is a common condition in the US gen

103 Chronic rhinosinusitis (CRS) is a common disease with still uncl

104 Chronic rhinosinusitis (CRS) is a common inflammatory condition

105 Chronic rhinosinusitis (CRS) is a common, heterogeneous upper ai

106 Chronic rhinosinusitis (CRS) is a complex disease consisting of

107 Chronic rhinosinusitis (CRS) is a complex upper airway inflammat

108 Chronic rhinosinusitis (CRS) is a complex, heterogenous conditio

109 Chronic rhinosinusitis (CRS) is a disease characterized by infla

110 Chronic rhinosinusitis (CRS) is a frequent condition that is tre

111 Chronic rhinosinusitis (CRS) is a heterogeneous disease characte

112 Chronic rhinosinusitis (CRS) is a heterogeneous disease characte

113 Chronic rhinosinusitis (CRS) is a heterogeneous disease, with pa

114 Chronic rhinosinusitis (CRS) is a multifactorial disease of the

115 Chronic rhinosinusitis (CRS) is a prevalent condition with under

116 Chronic rhinosinusitis (CRS) is a prevalent multifactorial disea

117 Chronic rhinosinusitis (CRS) is a troublesome, chronic inflammat

118 Chronic rhinosinusitis (CRS) is an inflammation of the nose and

119 Chronic rhinosinusitis (CRS) is an inflammatory disease of the u

120 Chronic rhinosinusitis (CRS) is an inflammatory disease that aff

121 Chronic rhinosinusitis (CRS) is an inflammatory process in the n

122 Evidence shows that chronic rhinosinusitis (CRS) is associated with prior presence o

123 Chronic rhinosinusitis (CRS) is complicated by frequent acute ex

124 Although chronic rhinosinusitis (CRS) is considered the most treatable fo

125 erstanding of the pathophysiology of chronic rhinosinusitis (CRS) is continuously evolving.

126 ranasal sinuses for diseases such as chronic rhinosinusitis (CRS) is particularly challenging because

127 Chronic rhinosinusitis (CRS) is thought to result from complex i

128 The prevalence of chronic rhinosinusitis (CRS) measured in epidemiologic studies i

129 us, age-related cytokine profiles in chronic rhinosinusitis (CRS) need to be investigated for precisi

130 Chronic rhinosinusitis (CRS) occurs in >10% of the adult populat

131 Patients with chronic rhinosinusitis (CRS) often have comorbid asthma.

132 of the underlying cause or causes of chronic rhinosinusitis (CRS) over the past 20 or more years have

133 Potential effects of aging on chronic rhinosinusitis (CRS) pathophysiology have not been well

134 ently, ILC2s enrichment was noted in chronic rhinosinusitis (CRS) patients; however, the role of ILC2

135 The cause of chronic rhinosinusitis (CRS) remains unclear.

136 Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is a chr

137 Although chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is chara

138 Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is well

139 s, were collected from patients with chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) or witho

140 as obtained from subjects with AERD, chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), CRS wit

141 Chronic rhinosinusitis (CRS) with nasal polyps is a common chron

142 g endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) without nasal polyposis, there are

143 Chronic rhinosinusitis (CRS) without nasal polyps (CRSsNP) and C

144 Chronic rhinosinusitis (CRS) without nasal polyps (CRSsNP) is a

145 osinophilia, which is in contrast to chronic rhinosinusitis (CRS) without nasal polyps (NPs).

146 ronchodilator lung function, asthma, chronic rhinosinusitis (CRS), and atopy with age using a large E

147 mucosal diseases, including asthma, chronic rhinosinusitis (CRS), and eosinophilic esophagitis.

148 is a prominent feature of asthma and chronic rhinosinusitis (CRS), and the endothelium plays a key ro

149 nasal polyps (NPs) of patients with chronic rhinosinusitis (CRS), as well as in bronchoalveolar lava

150 the high prevalence and morbidity of chronic rhinosinusitis (CRS), little is known about the mechanis

151 tems, we identified respondents with chronic rhinosinusitis (CRS), migraine headache, and fatigue sym

152 ed outcomes during the management of chronic rhinosinusitis (CRS), PROMs will play an essential role

153 ithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS), respectively.

154 obulin deficiencies in patients with chronic rhinosinusitis (CRS).

155 sample with subjects with asthma and chronic rhinosinusitis (CRS).

156 fibrinolytic system in patients with chronic rhinosinusitis (CRS).

157 coagulation factors in patients with chronic rhinosinusitis (CRS).

158 t roles in inflammatory processes in chronic rhinosinusitis (CRS).

159 osis but have not been implicated in chronic rhinosinusitis (CRS).

160 ically investigated in patients with chronic rhinosinusitis (CRS).

161 ithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS).

162 plays a role in the exacerbation of chronic rhinosinusitis (CRS); however, the mechanism for this is

163 ]) with CRS and nasal polyps/allergic fungal rhinosinusitis (CRSwNPs+).

164 -to-treat CRS was defined as noncontrollable rhinosinusitis despite successful sinus surgery and appr

165 Most cases of acute rhinosinusitis diagnosed in ambulatory care are caused b

166 definitive diagnosis of eosinophilic chronic rhinosinusitis (eCRS) requires invasive surgical tissue

167 e asthma complicated by eosinophilic chronic rhinosinusitis (ECRS).

168 affected organs in asthma, rhinitis, chronic rhinosinusitis, eosinophilic esophagitis, food allergy,

169 study to use the European Position Paper on Rhinosinusitis (EPOS) criteria to study the prevalence o

170 ifficult to distinguish from acute bacterial rhinosinusitis, especially during the first 10 days of s

171 s with CRS, which was defined as symptomatic rhinosinusitis for more than 12 weeks and documented imm

172 hould reserve antibiotic treatment for acute rhinosinusitis for patients with persistent symptoms for

173 rs may impact upon airway disease, including rhinosinusitis, gastroesophageal reflux disease, obesity

174 morbidities are discussed: rhinitis, chronic rhinosinusitis, gastroesophageal reflux, obstructive sle

175 Invasive disease includes indolent chronic rhinosinusitis, granulomatous fungal sinusitis, and acut

176 Chronic rhinosinusitis has a significant impact on patient quali

177 onship between allergic rhinitis and chronic rhinosinusitis has been assessed in a number of observat

178 surgery and antibiotics in managing chronic rhinosinusitis has contributed to a five-times variation

179 We found that patients with chronic rhinosinusitis have elevated glucose concentrations in t

180 (HR 1.272, 95% CI 1.214-1.333), and chronic rhinosinusitis (HR 1.744, 95% CI 1.671-1.821).

181 tial management of suspected acute bacterial rhinosinusitis in adults and children were prepared by a

182 and treatment of acute maxillary and ethmoid rhinosinusitis in adults who are not immunocompromised.

183 Complications of acute bacterial rhinosinusitis in children are rare.

184 orticosteroids are beneficial to treat acute rhinosinusitis in patients with a history of chronic or

185 hould reserve antibiotic treatment for acute rhinosinusitis in patients with persistent symptoms for

186 robiota: Staphylococcus aureus infection and rhinosinusitis in the nasal-sinus mucosa, as well as cys

187 e bacteria commonly associated with clinical rhinosinusitis in vitro.

188 r 10 days, the likelihood of acute bacterial rhinosinusitis increases, and initiation of antibiotic t

189 smitted infections, cystic fibrosis, chronic rhinosinusitis, inflammatory bowel disease, and glaucoma

190 Acute rhinosinusitis is a common ailment accounting for millio

191 Rhinosinusitis is a common condition which may present w

192 Chronic rhinosinusitis is a consistent feature of the autosomal

193 The pathogenesis of chronic rhinosinusitis is a growing area of interest, but there

194 Acute bacterial rhinosinusitis is an infection of the nasal epithelium a

195 Chronic rhinosinusitis is characterized by persistent locoregion

196 Chronic rhinosinusitis is common and sometimes complicated by na

197 ce to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly

198 D (n = 15), Rhinitis and Asthma (n = 5), and Rhinosinusitis (n = 6).

199 e included acute inflammation (n=6), chronic rhinosinusitis (n=2), and allergic rhinitis (n=20) and u

200 Patients develop chronic eosinophilic rhinosinusitis, nasal polyposis, and asthma.

201 Recurrent CRS was defined as rhinosinusitis not controlled by appropriate conservativ

202 onize the respiratory tract and cause fungal rhinosinusitis or bronchopulmonary aspergillosis.

203 etions in pathologic states, such as chronic rhinosinusitis or hyperglycemia, promotes tonic activati

204 e cases, given the likelihood of acute viral rhinosinusitis or of spontaneously resolving acute bacte

205 ing disease (asthma, nasal polyps or chronic rhinosinusitis, or both), as well as on the methodology

206 cough, recurrent chest infections, perennial rhinosinusitis, otitis media with effusion, and bronchie

207 es (Short-Form Health Questionnaire, 31-item Rhinosinusitis Outcome Measuring Instrument, and Asthma

208 onic obstructive pulmonary disease, acquired rhinosinusitis, pancreatitis, and lethal secretory diarr

209 Chronic rhinosinusitis patients with 1 CF mutation were evaluate

210 s flavus which is a common cause of allergic rhinosinusitis, postoperative aspergillosis and fungal k

211 gh rarely some patients with acute bacterial rhinosinusitis present with dramatic symptoms of severe

212 Adult patients with eosinophilic chronic rhinosinusitis received 100mg mepolizumab subcutaneously

213 ve traditionally guided treatment in chronic rhinosinusitis, recent research has favored categorizati

214 s and treatment of acute viral and bacterial rhinosinusitis recommend that the diagnosis of acute rhi

215 Adults (aged >=18 years) with chronic rhinosinusitis remaining symptomatic following appropria

216 Acute rhinosinusitis resolves without antibiotic treatment in

217 The clinical diagnosis of acute bacterial rhinosinusitis should be reserved for patients with rhin

218 mptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking status, and history of NSAID-ind

219 ed from malignant disease or invasive fungal rhinosinusitis, so an understanding of the clinical feat

220 level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria.

221 controlled based on evaluation of VAS global rhinosinusitis symptom score compared to 40.9% based on

222 AIDs was higher in participants with chronic rhinosinusitis symptoms (Odds Ratio 2.12; 95%CI 1.78-2.7

223 nusitis should be reserved for patients with rhinosinusitis symptoms lasting 7 days or more who have

224 Patients with rhinosinusitis symptoms that last less than 7 days are u

225 ial rhinosinusitis and for those with severe rhinosinusitis symptoms-especially those with unilateral

226 of neural and mucosal dysregulation in each rhinosinusitis syndrome.

227 Among patients with nasal polyps and chronic rhinosinusitis, the prevalence was 9.69% (95% CI, 2.16%

228 rflow is also a contributing factor in human rhinosinusitis, this in vivo model demonstrates for the

229 edius range in severity from bite wounds and rhinosinusitis to endocarditis; historically, these infe

230 mechanism in patients with aspirin-sensitive rhinosinusitis to the bronchial mucosa in patients with

231 pecimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR,

232 ) patients with clinical features of chronic rhinosinusitis were examined; patients with first-onset

233 ed trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practice

234 Chronic rhinosinusitis with a type 2 inflammatory pattern (T2CRS

235 Chronic rhinosinusitis with nasal polyposis (CRSwNP) in Western

236 Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a type 2

237 Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a type 2

238 Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an infla

239 Chronic rhinosinusitis with nasal polyposis (CRSwNP) is associat

240 Chronic rhinosinusitis with nasal polyposis (CRSwNP) negatively

241 itis (AFRS) is a severe phenotype of chronic rhinosinusitis with nasal polyposis (CRSwNP), characteri

242 role for mast cells is suggested in chronic rhinosinusitis with nasal polyposis (CRSwNP), which is c

243 se (AERD) is a condition composed of chronic rhinosinusitis with nasal polyposis and asthma that is d

244 een observed in patients with severe chronic rhinosinusitis with nasal polyposis and chronic obstruct

245 a subgroup of adults with asthma and chronic rhinosinusitis with nasal polyposis.

246 s in atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and eosinophil

247 The majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and over half

248 ncinate tissue (UT) of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and those with

249 A number of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) are resistant

250 Chronic rhinosinusitis with nasal polyps (CRSwNP) associated wit

251 Chronic rhinosinusitis with nasal polyps (CRSwNP) can be a sever

252 Chronic rhinosinusitis with nasal polyps (CRSwNP) causes nasal o

253 Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have

254 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic i

255 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex i

256 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predomina

257 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent

258 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 in

259 Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated

260 Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated

261 Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated

262 Although chronic rhinosinusitis with nasal polyps (CRSwNP) is characteriz

263 Chronic rhinosinusitis with nasal polyps (CRSwNP) is characteriz

264 Chronic rhinosinusitis with nasal polyps (CRSwNP) is generally a

265 Chronic rhinosinusitis with nasal polyps (CRSwNP) is often chara

266 1 and its ligands PD-L1 and PD-L2 in chronic rhinosinusitis with nasal polyps (CRSwNP) is poorly stud

267 is without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) using real-wor

268 rogenitor cells (BSCs) obtained from chronic rhinosinusitis with nasal polyps (CRSwNP) when different

269 e (AERD) is characterized by asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and an intole

270 sitis without nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and aspirin-e

271 RD) is characterized by the triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and i

272 mechanistically distinct subtype of chronic rhinosinusitis with nasal polyps (CRSwNP).

273 never been assessed in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

274 icoid receptor (GR) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

275 e mucosa obtained from patients with chronic rhinosinusitis with nasal polyps (n = 7) and patients wi

276 5%] female and 333 [65%] male), with chronic rhinosinusitis with nasal polyps (n=410) or chronic rhin

277 Chronic rhinosinusitis with nasal polyps (NP) and allergic rhini

278 irway inflammatory diseases, such as chronic rhinosinusitis with nasal polyps and asthma, show increa

279 in the initiation and persistence of chronic rhinosinusitis with nasal polyps and asthma.

280 disease compared with patients with chronic rhinosinusitis with nasal polyps and/or asthma alone.

281 r in as many as 15% of patients with chronic rhinosinusitis with nasal polyps and/or asthma.

282 g the trend in asthma, endotypes for chronic rhinosinusitis with nasal polyps have been established,

283 piratory disease is a severe form of chronic rhinosinusitis with nasal polyps in which nearly all pat

284 Chronic rhinosinusitis with nasal polyps is associated with loca

285 Chronic rhinosinusitis with nasal polyps is characterized by TH2

286 diseases such as atopic dermatitis, chronic rhinosinusitis with nasal polyps, and asthma.

287 aracterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and a hypersen

288 aracterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and an intoler

289 atment of asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, or chronic spontaneous

290 or 3 months for severe asthma and/or chronic rhinosinusitis with nasal polyps.

291 airways of patients with asthma and chronic rhinosinusitis with nasal polyps.

292 ost from infections in patients with chronic rhinosinusitis with nasal polyps.

293 and quality of life in patients with chronic rhinosinusitis with NPs.

294 ed to some inflammatory disorders as asthma, rhinosinusitis with polyposis, and atopic dermatitis, he

295 of premorbid medical conditions for chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic

296 9, at lower extent, in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) in comparis

297 LFs) from controls and patients with chronic rhinosinusitis without nasal polyps (CRSsNP), chronic rh

298 nasal polyps (CRSwNP) and those with chronic rhinosinusitis without nasal polyps (CRSsNP; P < .01).

299 nusitis with nasal polyps (n=410) or chronic rhinosinusitis without nasal polyps (n=104), were recrui

300 from control subjects, patients with chronic rhinosinusitis without nasal polyps, and patients with c